Do You Regain Weight After Stopping Semaglutide or Tirzepatide?

What the Studies Actually Show

Most weight loss websites bury this topic. We would rather you hear it from us: in the STEP 1 trial extension, participants who discontinued semaglutide and its lifestyle support regained about two-thirds of their lost weight within twelve months. In SURMOUNT-4, participants switched from tirzepatide to placebo regained substantially, while those who continued treatment kept losing.

The lesson from the data is not "GLP-1s fail." It is that obesity behaves like other chronic conditions: treatment manages the underlying biology, and stopping treatment lets the biology speak again.

Why Regain Happens

GLP-1 medications quiet the hormonal signals that drive hunger and food noise. When the medication stops, appetite hormones shift back, often amplified by the body's natural defense of its previous weight. Willpower did not fail — the biology simply resumed. That framing matters, because it points to solutions that work with the biology instead of against it.

Five Ways to Protect Your Results

1. Build the maintenance base during treatment: strength training and protein-first eating preserve muscle, which defends your metabolic rate.
2. Never stop abruptly: a provider-guided taper beats a hard stop.
3. Ask about maintenance dosing: many patients hold results on a lower ongoing dose.
4. Plan the transition like a phase, not an ending: schedule follow-ups for the months after any change.
5. Treat regain early if it starts: restarting or adjusting treatment early is far easier than starting over.

FitFlow members keep access to their care team through and beyond treatment — the transition plan is part of the program, not an upsell. Questions about your own situation belong with a licensed provider, and that conversation is exactly what the online visit is for.